Rallybio RLYB
NASDAQ RLYB
$16.60 -0.40 (-2.35%)
At close: Aug 20, 2026 · 4:00 PM EDT

Rallybio (RLYB) Revenue (2024 - 2026)

Rallybio (RLYB) posted Revenue of $212000.0 for Q1 2026, down 4.5% sequentially from $222000.0 in Q4 2025, and little changed YoY from $212000.0 in Q1 2025.

Rallybio (RLYB) Revenue (2024 - 2026) Analysis & Trends

Rallybio has reported Revenue for 3 years, with the latest figure at $212000.0 in Q1 2026.

  • Quarterly Revenue changed 0.0% year-over-year to $212000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $858000.0 (up 1.18% YoY) and the FY2025 annual result came in at $858000.0, up 34.91% from the prior year.
  • Revenue declined to $212000.0 in Q1 2026 per RLYB's latest filing, from $222000.0 in the prior quarter.
  • Over five years, Revenue peaked at $299000.0 in Q2 2024 and troughed at $38000.0 in Q4 2024.
  • A 3-year average of $213250.0 and a median of $212000.0 in 2025 frame the typical range for Revenue.
  • The widest YoY moves for Revenue: up 484.21% in 2025, down 29.1% in 2025.
  • Over 3 years, Revenue stood at $38000.0 in 2024, then soared by 484.21% to $222000.0 in 2025, then dropped by 4.5% to $212000.0 in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $212000.0, $222000.0, and $212000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.52 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.29 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 425.49 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 674.14 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 1.06 Bn
10 Rallybio 95.20 Mn 95.20 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 212,000.00
Dec 31, 2025 222,000.00
Sep 30, 2025 212,000.00
Jun 30, 2025 212,000.00
Mar 31, 2025 212,000.00
Dec 31, 2024 38,000.00
Sep 30, 2024 299,000.00
Jun 30, 2024 299,000.00